Skip to content
Menu
About Us
Company Overview
Management
Board of Directors
Our Science
Overview of Assets
Science
Pipeline
Clinical Trials
Expanded Access Policy
Newsroom
Press Releases
Events & Presentations
Investor Relations
Corporate Governance
Financial Information
Annual Reports & Proxy Statements
Investor Contact Info
Contact
Close Menu
Press Releases
December 14, 2021
Panbela Announces Positive Preclinical Data Strongly Supporting the Activity of SBP-101 in Ovarian Cancer Cell Lines
Development Program for SBP-101’s Expansion into Ovarian Cancer Expected in 1H 2022
View/download press release »
Sign up to receive press releases via email
Leave this field empty if you're human: